Add to ORKGaggressive gastrointestinal tumour. It represents the fourth leading cause of cancer related deaths in both for its aggressive biological behaviour remain unclear. Therefore, new drugs for pancreatic adenocarcinoma are Dovzhanskiy et al. BMC Cancer 2012, 12:22
Despite the extensive research, mounting knowledge in the cancer field and enormous investments, pan...
1CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), Mall Road,Background Pancreatic can...
A number of preclinical studies have demonstrated an-ticancer effects for curcumin in various types ...
Pancreatic cancer is one of the most insidious forms of human cancer whose incidence nearly equals i...
Pancreatic cancer is the 10th most common cancer and 4th cause of cancer related deaths. Progress in...
Metastatic pancreatic cancer continues to be a difficult disease to treat because of its aggressive ...
Pancreatic adenocarcinoma is one of the most aggressive malignancies and the fourth leading cause of...
Over the last twenty years, there is a limited number of effective cytotoxic or biological agents th...
The high mortality rate of pancreatic cancer places this uncommon malignancy quite high as a cause o...
it Pancreatic cancer (PC) is a devastating disease. Gemcitabine has been the standard therapy for ex...
A landmark seven year study has identified that pancreatic cancer is not one, but four types of canc...
There is currently tremendous interest in developing anti-cancer therapeutics targeting cell signali...
Purpose: Pancreatic carcinoma is the most lethal cancer, with a 5‑year survival rate of <5%. Hype...
The current role of chemotherapy in pancreatic cancer is limited. Chemotherapy usually consists of 5...
Pancreatic cancer is the fourth leading cause of cancer death in the United States and has a lower s...
Despite the extensive research, mounting knowledge in the cancer field and enormous investments, pan...
1CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), Mall Road,Background Pancreatic can...
A number of preclinical studies have demonstrated an-ticancer effects for curcumin in various types ...
Pancreatic cancer is one of the most insidious forms of human cancer whose incidence nearly equals i...
Pancreatic cancer is the 10th most common cancer and 4th cause of cancer related deaths. Progress in...
Metastatic pancreatic cancer continues to be a difficult disease to treat because of its aggressive ...
Pancreatic adenocarcinoma is one of the most aggressive malignancies and the fourth leading cause of...
Over the last twenty years, there is a limited number of effective cytotoxic or biological agents th...
The high mortality rate of pancreatic cancer places this uncommon malignancy quite high as a cause o...
it Pancreatic cancer (PC) is a devastating disease. Gemcitabine has been the standard therapy for ex...
A landmark seven year study has identified that pancreatic cancer is not one, but four types of canc...
There is currently tremendous interest in developing anti-cancer therapeutics targeting cell signali...
Purpose: Pancreatic carcinoma is the most lethal cancer, with a 5‑year survival rate of <5%. Hype...
The current role of chemotherapy in pancreatic cancer is limited. Chemotherapy usually consists of 5...
Pancreatic cancer is the fourth leading cause of cancer death in the United States and has a lower s...
Despite the extensive research, mounting knowledge in the cancer field and enormous investments, pan...
1CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), Mall Road,Background Pancreatic can...
A number of preclinical studies have demonstrated an-ticancer effects for curcumin in various types ...